Alerje is at the forefront of combating food allergies, which affect 220 million people globally, by integrating emergency medicine with AI enabled digital health tools. Their remote patient monitoring platform, backed by the National Science Foundation, revolutionizes food allergy immunotherapy management through advanced data analytics. Their platform not only gathers and processes vital information but also predicts treatment outcomes, enhancing care strategies for allergists. Alerje’s internationally patented technology combines a low-cost life-saving epinephrine auto-injector with a smartphone case, ensuring patients have immediate access to medication, thus redefining adherence and emergency response.